XML 22 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues:        
Revenues $ 49,959 $ 2,871 $ 69,018 $ 7,694
Expenses        
Cost of product sales 297 0 6,220 0
Research and development 52,873 27,498 95,308 57,365
Selling, general and administrative 26,325 13,883 48,439 29,748
Royalty 46 0 10 69
Total operating expenses 79,541 41,381 149,977 87,182
Loss from operations (29,582) (38,510) (80,959) (79,488)
Interest and other income 13 2,758 39 9,204
Interest expense (13,495) (2,918) (26,399) (5,965)
(Loss) gain on foreign currency (134) 63 (163) 43
Net loss (43,198) (38,607) (107,482) (76,206)
Foreign currency translation adjustment (92) 0 86 0
Unrealized (loss) gain on available for sale investments (3) (11) (2) (36)
Comprehensive loss $ (43,293) $ (38,618) $ (107,398) $ (76,242)
Basic and diluted net loss per common share (in dollars per share) $ (240) $ (240) $ (600) $ (480)
Weighted average shares outstanding (in shares) 178,127 161,569 177,737 157,862
Product [Member]        
Revenues:        
Revenues $ 33,430 $ 0 $ 51,301 $ 218
Royalty [Member]        
Revenues:        
Revenues 128 44 (769) 1,989
Milestone [Member]        
Revenues:        
Revenues 15,000 0 15,000 0
Collaborative and Other Research and Development [Member]        
Revenues:        
Revenues $ 1,401 $ 2,827 $ 3,486 $ 5,487